$14.37 B
Share price
Change (1 day)
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Market capitalization of Bio-Techne (TECH)

Market cap: $14.37 Billion

As of May 2022 Bio-Techne has a market cap of $14.37 Billion. This makes Bio-Techne the world's 1120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Bio-Techne from 2001 to 2022

Year Market cap Change
2022$14.37 B-29.3%
2021$20.32 B65.81%
2020$12.26 B45.9%
2019$8.40 B53.88%
2018$5.46 B12.52%
2017$4.85 B26.5%
2016$3.83 B14.62%
2015$3.34 B-2.38%
2014$3.42 B-1.84%
2013$3.49 B38.75%
2012$2.51 B-0.31%
2011$2.52 B3.61%
2010$2.43 B-4.58%
2009$2.55 B5.61%
2008$2.41 B-6.6%
2007$2.58 B18.56%
2006$2.18 B0.17%
2005$2.18 B35.67%
2004$1.60 B3.5%
2003$1.55 B30.89%
2002$1.18 B-22.43%
2001$1.52 B

End of Day market cap according to different sources

On May 21st, 2022 the market cap of Bio-Techne was reported to be:

$14.37 Billion
by Nasdaq
$14.37 Billion
by CompaniesMarketCap
$14.37 Billion
by Iex Cloud
$14.39 Billion
by Yahoo Finance

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$217.32 B 1,411.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$71.92 B 400.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.82 B 476.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$183.07 B 1,173.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.29 B-28.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.11 B-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.64 B 8.84%๐Ÿ‡บ๐Ÿ‡ธ USA